Next Article in Journal
Prostate Cancer—PET Imaging Update
Next Article in Special Issue
Reply to Lissing et al. Comment on “Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947”
Previous Article in Journal
CAR-T Cell Therapy and the Gut Microbiota
Previous Article in Special Issue
Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature
 
 
Comment
Peer-Review Record

Comment on Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947

Cancers 2023, 15(3), 795; https://doi.org/10.3390/cancers15030795
by Mattias Lissing 1,2,*, Daphne Vassiliou 3,4,5, Pauline Harper 4,6, Eliane Sardh 3,4,5 and Staffan Wahlin 1,2
Reviewer 1: Anonymous
Cancers 2023, 15(3), 795; https://doi.org/10.3390/cancers15030795
Submission received: 23 August 2022 / Accepted: 17 January 2023 / Published: 28 January 2023

Round 1

Reviewer 1 Report

This manuscript contains important comments to previously published articles. Present the missing literature during the article, present the latest results of several studies, including an important cohort study, and potentially better interpret and discuss the results in the article. For these reasons, I believe that this comment should be accepted and made available to authors and readers.

Back to TopTop